Tatva Chintan Pharma Chem (BOM:543321) Research & Development: ₹0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543321 Tatva Chintan Pharma Chem Ltd BOM:543321
79 GF Score
Price ₹1,428.45
GF Value ₹1,491.99
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Tatva Chintan Pharma Chem Research & Development?

Tatva Chintan Pharma Chem BOM:543321 +0.85% 79 Research & Development is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:543321 with a GF Score™ of 79/100 and a GF Value™ of ₹1,491.99 (Fairly Valued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Tatva Chintan Pharma Chem's Research & Development for the three months ended in Jun. 2026 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 was ₹0 Mil.

Tatva Chintan Pharma Chem  (BOM:543321) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Tatva Chintan Pharma Chem Research & Development Related Terms

Tatva Chintan Pharma Chem Research & Development Historical Data

* Premium members only.

The historical data trend for Tatva Chintan Pharma Chem's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tatva Chintan Pharma Chem Research & Development Chart

Tatva Chintan Pharma Chem Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Tatva Chintan Pharma Chem Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:543321
79GF Score
Tatva Chintan Pharma Chem Ltd BOM:543321
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tatva Chintan Pharma Chem Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0 Mil mean?
Tatva Chintan Pharma Chem (BOM:543321) has a Research & Development of ₹0 Mil as of Jun. 2026. Research and development expense is the total cost for research and development activities. View historical data on Tatva Chintan Pharma Chem and its competitors.
Is Tatva Chintan Pharma Chem's Research & Development too high?
Tatva Chintan Pharma Chem's current Research & Development is ₹0 Mil. Overall, Tatva Chintan Pharma Chem has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Tatva Chintan Pharma Chem's Research & Development compare to LIN and SHW?
Tatva Chintan Pharma Chem's Research & Development of ₹0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Chemicals company?
A good Research & Development depends on the Chemicals industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Tatva Chintan Pharma Chem and its competitors. Tatva Chintan Pharma Chem's current Research & Development is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tatva Chintan Pharma Chem stock overvalued right now?
Based on GuruFocus' analysis, Tatva Chintan Pharma Chem (BOM:543321) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,491.99, compared to a current price of ₹1,428.45 — trading 4.3% below its estimated fair value. The current Research & Development is ₹0 Mil. Tatva Chintan Pharma Chem's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Tatva Chintan Pharma Chem (BOM:543321), the current Research & Development is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tatva Chintan Pharma Chem (BOM:543321) Overvalued in 2026?

Based on GuruFocus' analysis, Tatva Chintan Pharma Chem stock appears to be undervalued. The current stock price of ₹1,428.45 is trading 4.3% below its estimated GF Value™ of ₹1,491.99. GuruFocus considers Tatva Chintan Pharma Chem to be Fairly Valued.

Key valuation signals for BOM:543321:

  • Research & Development: ₹0 Mil
  • GF Value™: ₹1,491.99 vs. price of ₹1,428.45 (4.3% below fair value)
  • GF Score™: 79/100 with 6 warning signs

No single metric tells the full story. See the BOM:543321 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tatva Chintan Pharma Chem Business Description

Other Exchanges TATVA:India
Address Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.
79GF Score

Get the complete analysis for BOM:543321

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,428.45
Price
₹1,491.99
GF Value